Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/1995
05/18/1995WO1995013377A1 Episomal expression vector for human gene therapy
05/18/1995WO1995013375A1 Tumor suppressor waf1
05/18/1995WO1995013289A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/18/1995WO1995013271A1 Novel taxoids, their preparation and pharmaceutical compositions containing them
05/18/1995WO1995013090A1 Improved interferon polymer conjugates
05/18/1995WO1995013079A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
05/18/1995WO1995013071A2 Treatment of immunoregulatory disorders
05/18/1995WO1995013062A1 Butyric ester cyto-differentiating agents
05/18/1995WO1995013061A1 Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation
05/18/1995WO1995013059A1 Farnesyl derivatives and pharmaceutical compositions containing them
05/18/1995WO1995013053A1 Taxol formulation
05/18/1995CA2176386A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
05/18/1995CA2176013A1 Treatment of immunoregulatory disorders
05/18/1995CA2175384A1 Novel taxoids, their preparation and pharmaceutical compositions containing them
05/18/1995CA2175249A1 Butyric ester cyto-differentiating agents
05/18/1995CA2173470A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/17/1995EP0653439A2 Stabilized oligonucleotids and the use thereof
05/17/1995EP0652952A1 Peptides inhibiting ras protein activity, preparation and use thereof
05/17/1995EP0652948A1 Development of a vector to target gene expression to the epidermis of transgenic animals
05/17/1995EP0652903A1 NEW HUMAN RECOMBINANT $g(g) INTERFERON
05/17/1995EP0652897A1 Peptide inhibitors of selectin binding
05/17/1995EP0652890A1 Oligonucleotide alkylphosphonothioates
05/17/1995EP0652871A1 Benzodiazepine derivatives
05/17/1995EP0652864A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds
05/17/1995EP0652863A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression
05/17/1995EP0652749A1 METHODS AND COMPOSITIONS FOR INHIBITING 5$g(a)-REDUCTASE ACTIVITY
05/17/1995CN1102643A Substituted derivatives of diaminophthalimide
05/17/1995CN1102570A Snake poison anti-cancer medicine and its prepn.
05/17/1995CN1028427C Rhizoxin derivatives and their use as antitumor agents
05/16/1995US5416202 Such as gelonin, cysteine substitution
05/16/1995US5416117 Cyclopropenone derivatives
05/16/1995US5416091 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
05/16/1995US5416089 Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
05/16/1995US5416070 Composition for macrophage activation
05/16/1995US5415869 Taxol formulation
05/16/1995CA1335579C Beta-d-glucan, and its production and uses
05/16/1995CA1335572C Derivatives of cyclic amp as treatment for cancer
05/11/1995WO1995012678A2 Improvements relating to cancer therapy
05/11/1995WO1995012660A2 Recombinant p53 adenovirus methods and compositions
05/11/1995WO1995012612A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
05/11/1995WO1995012606A1 5-fluorouracil derivatives
05/11/1995WO1995012603A1 Matrix metalloprotease inhibitors________________________________
05/11/1995WO1995012592A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments
05/11/1995WO1995012584A1 Novel benzoyl guanidines, their production and their use in medicaments
05/11/1995WO1995012400A1 Novel enzyme inhibitors, their synthesis, and methods for use
05/11/1995WO1995012394A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995CA2175838A1 Novel benzoyl guanidines, their production and their use in medicaments
05/11/1995CA2175837A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments
05/11/1995CA2175667A1 Matrix metalloprotease inhibitors________________________________
05/11/1995CA2175467A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995CA2170766A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
05/10/1995EP0652232A1 P53as protein and antibody therefor
05/10/1995EP0652231A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS
05/10/1995EP0652228A1 Urethanes and ureas that induce cytokine production
05/10/1995EP0652226A1 Process of preparing etoposide phosphate and etoposide
05/10/1995EP0652214A1 N-Aryl-2-cyano-3-hydroxy propenamide derivatives, a method for their preparation, their use as medicaments and pharmaceutical compositions containing them
05/10/1995EP0652004A1 Methods for treating resistant neoplasms
05/10/1995EP0652000A1 Methods for inhibiting angiogenisis and angiogenic diseases
05/10/1995EP0651800A1 Basophil granule proteins
05/10/1995EP0651769A1 Leukaemia inhibitory factor-binding protein
05/10/1995EP0651750A1 Tetracyclic compounds process and intermediates for their preparation and their use as antitumour agents
05/10/1995EP0651740A1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours
05/10/1995EP0651738A1 Natural amino acid derivatives as metalloproteinase inhibitors
05/10/1995EP0651653A1 p53 VACCINE
05/10/1995EP0651646A1 Therapeutic conjugates of toxins and drugs
05/10/1995EP0651636A1 Chemotherapy for cancer
05/10/1995EP0548261B1 Spontaneously dispersible concentrate containing a sterol ester and sterol phosphatide respectively
05/10/1995EP0496835B1 Solid tumor treatment method and composition
05/10/1995CN1102324A Pharmaceutical composition
05/10/1995CN1028362C Deacetylcolchicine derivatives
05/10/1995CA2135265A1 Stable lyophilized thiotepa composition
05/09/1995US5414015 Anti-skin tumor promoting composition
05/05/1995CA2135044A1 N-aryl-2-cyano-3-hydroxypropenamides derivatives, proc ess for their preparation, their application as medicaments and pharmaceutical compositions containing them
05/04/1995WO1995011987A1 Chimeric proteins including protease nexin-1 variants
05/04/1995WO1995011984A2 Recombinant adenoviral vector and methods of use
05/04/1995WO1995011977A2 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA)
05/04/1995WO1995011924A1 Non-antigenic branched polymer conjugates
05/04/1995WO1995011917A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
05/04/1995WO1995011699A1 Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
05/04/1995WO1995011694A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
05/04/1995WO1995011687A1 Therapeutic use of cis-element decoys in vivo
05/04/1995WO1995011670A1 Liposomal defensins
05/04/1995CA2174943A1 A new ribosome-inactivating protein isolated from the plant bryonia dioica
05/04/1995CA2173590A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
05/03/1995EP0650953A1 Cyclised analogs of metabolites of fatty acids, process for their preparation and pharmaceutical compositions containing them
05/03/1995EP0650726A1 4-Piperidino-piperidine for the treatment of tumor
05/03/1995EP0650596A1 Compositions and methods for regulating cellular signal transducing systems
05/03/1995EP0650493A1 Hybrid oligonucleotide phosphorothioates
05/03/1995EP0650489A1 Rapamycin derivatives
05/03/1995EP0650372A1 Compounds for cancer imaging and therapy
05/03/1995EP0650371A1 Covalent polar lipid-peptide conjugates for biological targeting
05/03/1995EP0650368A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
05/03/1995EP0650357A1 Rapamycin derivatives
05/03/1995EP0650356A1 Rapamycin derivatives
05/03/1995EP0626953A4 Novel sidechain-bearing taxanes and intermediates thereof.
05/03/1995EP0535231B1 Pyrimidine nucleoside derivative
05/03/1995EP0470144B1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours
05/03/1995EP0379522B1 Uses of recombinant colony stimulating factor-1
05/03/1995EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives
05/03/1995CN1102213A Isolated peptides which form complexes with MHC molecule HLA-C-Clone 10 and uese thereof
1 ... 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 ... 2211